NRT Smoking Cessation Aids in Taiwan

October 2023 | 23 pages | ID: N821775D1E1EN
Euromonitor International Ltd

Abstracts

In keeping with the negative trajectory observed throughout the review period, NRT smoking cessation aids is set to contract in volume and current value terms in 2023. Demand continues to be undermined by the fact that the rate of smoking prevalence among the Taiwanese population and the total number of smokers in the country have been falling steadily for several years due to a combination of rising health-consciousness and increasingly stringent tobacco control policies. The latter include an...

Euromonitor International's NRT Smoking Cessation Aids in Taiwan report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2018-2022, allowing you to identify the sectors driving growth. Forecasts to 2027 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?

• Get a detailed picture of the NRT Smoking Cessation Aids market;
• Pinpoint growth sectors and identify factors driving change;
• Understand the competitive environment, the market’s major players and leading brands;
• Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.

Contents

NRT Smoking Cessation Aids in Taiwan
Euromonitor International
December 2023

LIST OF CONTENTS AND TABLES

NRT SMOKING CESSATION AIDS IN TAIWAN
KEY DATA FINDINGS

2023 DEVELOPMENTS

Overall demand continues to fall in line with long-term decline in smoking prevalence
State-subsidised alternatives inhibit use of NRT smoking cessation aids
GSK Consumer Healthcare and Johnson & Johnson still the clear leaders
PROSPECTS AND OPPORTUNITIES
Outlook for NRT smoking cessation aids remains negative
Personalised quitting plans and mobile apps will remain key marketing tools
Competitive landscape likely to remain highly consolidated
CATEGORY INDICATORS
Table 1 Number of Smokers by Gender 2018-2023
CATEGORY DATA
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2018-2023
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2018-2023
Table 4 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2019-2023
Table 5 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2020-2023
Table 6 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2023-2028
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2023-2028
CONSUMER HEALTH IN TAIWAN
EXECUTIVE SUMMARY
Consumer health in 2023: The big picture

2023 KEY TRENDS

Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2018-2023
Table 9 Life Expectancy at Birth 2018-2023
MARKET DATA
Table 10 Sales of Consumer Health by Category: Value 2018-2023
Table 11 Sales of Consumer Health by Category: % Value Growth 2018-2023
Table 12 NBO Company Shares of Consumer Health: % Value 2019-2023
Table 13 LBN Brand Shares of Consumer Health: % Value 2020-2023
Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2018-2023
Table 15 Distribution of Consumer Health by Format: % Value 2018-2023
Table 16 Distribution of Consumer Health by Format and Category: % Value 2023
Table 17 Forecast Sales of Consumer Health by Category: Value 2023-2028
Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2023-2028
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources